Robert Janssen - 16 Nov 2021 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role
Senior Vice President
Signature
/s/ Robert Janssen
Issuer symbol
DVAX
Transactions as of
16 Nov 2021
Net transactions value
-$593,701
Form type
4
Filing time
18 Nov 2021, 16:06:59 UTC
Previous filing
03 Sep 2021
Next filing
14 Feb 2022
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Robert Janssen filed Form 4 for DYNAVAX TECHNOLOGIES CORP (DVAX) on 18 Nov 2021."

Quick Takeaways

  • This page summarizes Robert Janssen's Form 4 filing for DYNAVAX TECHNOLOGIES CORP (DVAX).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Filing timestamp: 18 Nov 2021, 16:06.

What Changed

  • Previous filing in this sequence was filed on 03 Sep 2021.
  • Current net transaction value: -$593,701.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DVAX Common Stock Options Exercise $376,648 +35,974 +435% $10.47 44,250 16 Nov 2021 Direct
transaction DVAX Common Stock Sale $617,479 -35,974 -81% $17.16 8,276 16 Nov 2021 Direct F1
transaction DVAX Common Stock Options Exercise $559,423 +53,431 +646% $10.47 61,707 17 Nov 2021 Direct
transaction DVAX Common Stock Sale $912,292 -53,431 -87% $17.07 8,276 17 Nov 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DVAX Stock Option (Right to Buy) Options Exercise -35,974 -35% 67,126 16 Nov 2021 Common Stock 35,974 $10.47 Direct F3, F4
transaction DVAX Stock Option (Right to Buy) Options Exercise -53,431 -80% 13,695 17 Nov 2021 Common Stock 53,431 $10.47 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $17.01 to $17.27; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.
F2 This transaction was executed in multiple trades at prices ranging from $16.92 to $17.30; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.
F3 This option grant will vest over three (3) years with one-third (1/3) of the shares subject to the option vesting twelve months after the grant date, and one thirty-sixth (1/36) of the shares subject to the option vesting on the last day of each month thereafter.
F4 Not applicable

Sponsored